Stockreport

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF Current share price of US$83.78 suggests BioMarin Pharmaceutical is potentially 41% undervalued Our fair value estimate is 32% higher than BioMarin Pharmaceutical's a [Read more]